Circulating Tumor DNA as a Novel Biomarker Optimizing Treatment for Triple Negative Breast Cancer. Sun Y, Zhu C, Xu F, Cui S, et al. Clin Breast Cancer 2023 Mar 2:S1526-8209(23)00042.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun Y, Zhu C, Xu F, Cui S, et al. Circulating Tumor DNA as a Novel Biomarker Optimizing Treatment for Triple Negative Breast Cancer. Clin Breast Cancer 2023 Mar 2:S1526-8209(23)00042.
PMID: 36966079